Regeneron Pharmaceuticals Inc Regn Q3 2018 Earnings Conference Call Transcript | Latest News RSS feed
Regeneron Pharmaceuticals Inc Regn Q3 2018 Earnings Conference Call Transcript - Latest News
Regeneron Pharmaceuticals Inc (REGN) Q3 2018 Earnings Conference Call Transcript
Image source: The Motley Fool. Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q3 2018 Earnings Conference Call Nov. 06, 2018, 8:30 a.m. ET Operator Welcome to the Regeneron Pharmaceuticals Q3 2018 ... read more
Regeneron Pharmaceuticals' (REGN) CEO Leonard Schleifer on Q3 2016 Results - Earnings Call Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2016 Earnings Conference Call November 4, 2016 8:30 PM ET Executives Michael Aberman - Senior Vice President, Strategy and Investor Relations Leonard ... read more
Is a Beat in the Cards for Allergan (AGN) in Q3 Earnings?
Factors to Consider On the second-quarter conference call ... company has an Earnings ESP of +0.56% and is a Zacks #2 Ranked stock. You can see the complete list of today's Zacks #1 Rank stocks here. ... read more
Looking for another news?
Regeneron Pharmaceuticals Q3 Earnings Preview
On Tuesday, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release. Wall Street ... read more
Regeneron Investors Cheer Q3 Earnings Beat, Eylea Growth
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) reported its third-quarter financial results before the markets opened on Friday. The company posted $3.13 in earnings per share (EPS) on $1.22 billion in ... read more
Regeneron Pharmaceuticals (REGN) Q4 2017 Results - Earnings Call Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2017 Earnings Call February 8, 2018 8:30 ... As discussed at the JPMorgan conference last month, the 2018 benefit that we expect to realize from U.S. ... read more
Amgen (AMGN) to Report Q4 Earnings: What's in the Cards?
Aimovig/erenumab for prevention of migraine was approved and launched in the United States in second quarter of 2018. Aimovig was approved in EU in July. On the Q3 conference call ... include: ... read more
Regeneron Pharmaceuticals Inc (REGN) Q4 2018 Earnings Conference Call Transcript
REGN earnings call for the period ending December 31, 2018. Home Mail Search News Cricket Movies Lifestyle Celebrity Mobile Answers Groups More Yahoo Search Search Skip to Navigation Skip to Market ... read more